Showing 1 - 5 results of 5 for search 'Tapani Ruutu', query time: 0.02s Refine Results
  1. 1
    Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients

    Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients by Eeva Juvonen, Sanna Aalto, Jussi Tarkkanen, Liisa Volin, Klaus Hedman, Tapani Ruutu

    Published 2007-06-01
    Get full text
    Article
  2. 2
    Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

    Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group by Tapani Ruutu, Giovanni Barosi, Richard J. Benjamin, Richard E. Clark, James N. George, Alois Gratwohl, Ernst Holler, Massimo Iacobelli, Karim Kentouche, Bernhard Lämmle, Joel L. Moake, Paul Richardson, Gerard Socié, Zella Zeigler, Dietger Niederwieser, Tiziano Barbui

    Published 2007-01-01
    Get full text
    Article
  3. 3
    Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

    Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation by Nicolaus Kröger, Ronald Brand, Anja van Biezen, Axel Zander, Judith Dierlamm, Dietger Niederwieser, Agnès Devergie, Tapani Ruutu, Jackie Cornish, Per Ljungman, Alois Gratwohl, Catherine Cordonnier, Dietrich Beelen, Eric Deconinck, Argiris Symeonidis, Theo de Witte, for the Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

    Published 2009-04-01
    Get full text
    Article
  4. 4
    Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia

    Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia by Anne M. Dickinson, Kim F. Pearce, Jean Norden, Stephen G. O’Brien, Ernst Holler, Heike Bickeböller, Yesilda Balavarca, Vanderson Rocha, Hans-Jochem Kolb, Ilona Hromadnikova, Petr Sedlacek, Dietger Niederwieser, Ronald Brand, Tapani Ruutu, Jane Apperley, Richard Szydlo, Els Goulmy, Wolfgang Siegert, Theo de Witte, Alois Gratwohl

    Published 2010-06-01
    Get full text
    Article
  5. 5
    Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

    Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international... by Tapani Ruutu, Liisa Volin, Dietrich W. Beelen, Rudolf Trenschel, Juergen Finke, Marc Schnitzler, Jerzy Holowiecki, Sebastian Giebel, Miroslaw Markiewicz, Lutz Uharek, Igor W. Blau, Joachim Kienast, Matthias Stelljes, Kajsa Larsson, Axel R. Zander, Martin Gramatzki, Roland Repp, Hermann Einsele, Gernot Stuhler, Joachim Baumgart, Heidrun A. Mylius, Uwe Pichlmeier, Mathias Freund, Jochen Casper

    Published 2011-09-01
    Get full text
    Article

Search Tools: